OXURION NV (OXUR.BR) Fundamental Analysis & Valuation
EBR:OXUR • BE0974487192
Current stock price
0.004 EUR
0 (0%)
Last:
This OXUR.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. OXUR.BR Profitability Analysis
1.1 Basic Checks
- OXUR had positive earnings in the past year.
- In the past year OXUR has reported a negative cash flow from operations.
- In the past 5 years OXUR reported 4 times negative net income.
- OXUR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- OXUR has a better Return On Assets (39.34%) than 97.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 39.34% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 97950.00%, OXUR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- OXUR's Operating Margin of 45050.00% is amongst the best of the industry. OXUR outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45050% | ||
| PM (TTM) | 97950% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. OXUR.BR Health Analysis
2.1 Basic Checks
- OXUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- OXUR has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for OXUR has been increased compared to 5 years ago.
- OXUR has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -27.36, we must say that OXUR is in the distress zone and has some risk of bankruptcy.
- OXUR's Altman-Z score of -27.36 is on the low side compared to the rest of the industry. OXUR is outperformed by 86.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -27.36 |
ROIC/WACCN/A
WACC1.69%
2.3 Liquidity
- A Current Ratio of 0.17 indicates that OXUR may have some problems paying its short term obligations.
- The Current ratio of OXUR (0.17) is worse than 97.53% of its industry peers.
- OXUR has a Quick Ratio of 0.17. This is a bad value and indicates that OXUR is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of OXUR (0.17) is worse than 97.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.17 |
3. OXUR.BR Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 101.88% over the past year.
- The Revenue for OXUR has decreased by -97.62% in the past year. This is quite bad
- Measured over the past years, OXUR shows a very negative growth in Revenue. The Revenue has been decreasing by -76.22% on average per year.
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. OXUR.BR Valuation Analysis
4.1 Price/Earnings Ratio
- OXUR is valuated cheaply with a Price/Earnings ratio of 0.01.
- Based on the Price/Earnings ratio, OXUR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.89, OXUR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 86.42% of the companies in the same industry are more expensive than OXUR, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.54 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. OXUR.BR Dividend Analysis
5.1 Amount
- No dividends for OXUR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OXUR.BR Fundamentals: All Metrics, Ratios and Statistics
EBR:OXUR (4/17/2026, 7:00:00 PM)
0.004
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-03 2026-04-03/amc
Earnings (Next)09-09 2026-09-09
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap354.76K
Revenue(TTM)2.00K
Net Income(TTM)1.96M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.01 | ||
| Fwd PE | N/A | ||
| P/S | 177.38 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.54 |
EPS(TTM)0.61
EY15250%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 39.34% | ||
| ROE | N/A | ||
| ROCE | -7.59% | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 45050% | ||
| PM (TTM) | 97950% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 4.92 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.17 | ||
| Quick Ratio | 0.17 | ||
| Altman-Z | -27.36 |
F-Score4
WACC1.69%
ROIC/WACCN/A
Cap/Depr(3y)1.58%
Cap/Depr(5y)3.23%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y112.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.87%
OCF growth 3YN/A
OCF growth 5YN/A
OXURION NV / OXUR.BR Fundamental Analysis FAQ
What is the ChartMill fundamental rating of OXURION NV (OXUR.BR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OXUR.BR.
Can you provide the valuation status for OXURION NV?
ChartMill assigns a valuation rating of 3 / 10 to OXURION NV (OXUR.BR). This can be considered as Overvalued.
What is the profitability of OXUR stock?
OXURION NV (OXUR.BR) has a profitability rating of 3 / 10.
What are the PE and PB ratios of OXURION NV (OXUR.BR) stock?
The Price/Earnings (PE) ratio for OXURION NV (OXUR.BR) is 0.01 and the Price/Book (PB) ratio is -0.03.